New GP contract must support integrated primary care to deliver 10 Year Health Plan, says RPS
Published: 26 February 2026
This was published when the organisation was the Royal Pharmaceutical Society.
The Royal Pharmaceutical Society (RPS) has responded to the new GP contract announced by NHS England, highlighting the need for integrated primary care and full use of pharmacy expertise to help deliver the ambitions of the 10 Year Health Plan.
Amandeep Doll, RPS Director for England, said:
“Strengthening primary care is essential to delivering the 10 Year Health Plan and shifting more care into community settings. Developing new approaches to Neighbourhood Health, tackling obesity and boosting prevention must include pharmacy and be backed by sustainable investment.
“Realising the ambitions in the 10 Year Health Plan will depend on making the most of the whole of the NHS workforce. Pharmacists and pharmacy teams expand clinical capacity, improve access for patients and support the safe and effective use of medicines.
“Pharmacists working in general practice have improved patient access by supporting people with long-term conditions, offering medicines expertise and helping to free up GP appointments. Pharmacists recruited through the ARRS continue to make a significant difference and it’s vital they remain part of multidisciplinary teams to deliver high-quality patient care.
“With continued financial pressures, pharmacists must be adequately resourced, including in system leadership roles, to help deliver best value from medicines for patients and the NHS.”
Read more RPS news stories.
Related news
Prescription charge in England frozen for 2025
This news story was published when the organisation was the Royal Pharmaceutical Society. Commenting on the government's announcement today that the cost of the prescription charge and pre-payment certificates in England have been frozen for 2025/2026, Chair of RPS England Tase Oputu said: “This is a welcome pause in the otherwise relentless rise of the prescription charge for patients. No-one should face a financial barrier to get the medicines they need to stay well. “Pharmacists tell us they regularly see patients going without essential, life-saving medicines because they can’t afford all the items they’ve been prescribed. “When patients can’t afford their medicines, their health suffers, leading to more GP appointments, an increased risk of hospital admissions and added pressure on the NHS. Today’s news rightly recognises the key role that medicines play in helping people stay health and shifting care closer to home. “Millions of pounds are spent each year policing a complex prescription charges system that puts avoidable strain on patients and pharmacy teams alike. I hope the Government can build on today’s announcement, listen to the concerns of patients and health professionals, and bring about an end to unaffordable prescription charges in England.” The prescription charge will remain at £9.90 per item; a 3-month prescription prepayment certificate will be frozen at £32.05 and a 12-month certificate will remain at £114.50.
Professor Mahendra G Patel OBE awarded Honorary Fellowship by the Royal College of GPs
This news story was published when the organisation was the Royal Pharmaceutical Society. The Royal College of General Practitioners (RCGP) has awarded an Honorary Fellowship to Professor Mahendra G Patel OBE, recognising his exceptional contributions to healthcare, research equity and cross-professional leadership. Mahendra is an RPS Fellow, former member of the RPS English Pharmacy Board and previously held the post of RPS Treasurer. This accolade is the RCGP’s highest award for non-GPs. Starting in community pharmacy, Mahendra transitioned to academia, where he pioneered the National Institute for Health and Care Excellence (NICE) Student Champions Programme, embedding evidence-based practice and tackling health inequalities across the curricula of 40 medical, pharmacy, nursing and dental schools. He earned one of the first NICE Fellowships for his early leadership. As a Board member for RPS England, Mahendra led the development of national diabetes initiatives and a diabetes toolkit, while forging partnerships across professional boundaries and internationally. During the pandemic he played a crucial role in increasing diversity for the major 'PANORAMIC' and 'PRINCIPLE' COVID-19 trials, efforts which were recognised by the World Health Organization and the United Nations. He is the founding director of the Centre for Research Equity, Nuffield Department of Primary Care Health Sciences at the University of Oxford, shaping national research policy, collaborating with the RCGP and forming strategic partnerships across the UK. As co-lead of the NIHR-supported Race Equity Incubator, he is driving efforts to strengthen research capacity and capability while fostering equitable career progression for Black and minority ethnic healthcare professionals. A member of the UK Pharmacy Professional Leadership Advisory Board, Mahendra is a strong supporter of RPS becoming the Royal College of Pharmacy. He is also a BMJ NHS Commissioner and Professional Advisor to England’s Chief Pharmaceutical Officer. HSJ named him as one of the 50 most influential BAME figures in UK healthcare today. Professor Mahendra G Patel OBE said: “This stands as one of the proudest moments of my career, and for the pharmacy profession I represent, as RPS progresses to become the Royal College of Pharmacy. I hope this recognition becomes a catalyst: for closer collaboration, for shared leadership, and for inspiring members of both our professions to think beyond traditional boundaries – at every stage of their careers. “At a time of extraordinary pressures on general practice and pharmacy, joined-up thinking and integrated leadership across our professions has never been more urgent. I’ve always sought to break silos, widen access, and drive equity, with a clear focus on improving health outcomes by tackling the deep-rooted inequalities that persist across our communities. This Fellowship, for me, is not the culmination of that long journey, but the beginning of a renewed and fresh commitment.” RPS President Professor Claire Anderson said: “I’d like to offer my warmest congratulations to Mahendra on this prestigious Fellowship, which marks his huge contribution to the profession and healthcare. His work continues to inspire a new generation of pharmacists and researchers committed to equity, innovation, and collaborative leadership. Long may it continue.”